Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Mayrim V. Rios Perez

Matched on ORCID iD 0000-0001-5584-1315; OpenAlex author ID A5008087370. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: 2 papers · 2018: 1 paper · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers

Papers 13

  1. Retraction Note: Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarci… Co-author DOI 10.1038/s41418-024-01387-2↗
  2. Editor's Note: Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-24-1527↗
  3. CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Co-author DOI 10.1016/j.molmet.2021.101426↗
  4. CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. Co-author DOI 10.1200/po.19.00330↗
  5. Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical models. Co-author DOI 10.1016/j.sopen.2019.05.004↗
  6. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. First author DOI 10.1021/acs.jproteome.9b00132↗
  7. Hypoxia-induced autophagy of stellate cells inhibits expression and secretion of lumican into microenvironment of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41418-018-0207-3↗
  8. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-17-3668↗
  9. Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth. Co-author DOI 10.1038/onc.2017.125↗
  10. Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarci… Co-author DOI 10.1158/1535-7163.mct-16-0526↗
  11. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Co-author DOI 10.1158/1078-0432.ccr-15-2780↗
  12. Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-15-2936↗
  13. Regression of Stage IV Pancreatic Cancer to Curative Surgery and Introduction of a Novel Ex-Vivo Chemosensitivity Assay. Co-author DOI 10.7759/cureus.423↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jason B. Fleming · 13 shared papers, 2015–2024 · strength 1.26
  2. Ya’an Kang · 12 shared papers, 2016–2024 · strength 1.20
  3. Xinqun Li · 7 shared papers, 2016–2024 · strength 0.81
  4. David Roife · 8 shared papers, 2016–2024 · strength 0.77
  5. Bingbing Dai · 8 shared papers, 2015–2024 · strength 0.73
  6. Eugene Jon Koay · 7 shared papers, 2015–2024 · strength 0.61
  7. Michael P. Kim · 4 shared papers, 2018–2024 · strength 0.43
  8. Yeon‐Ju Lee · 4 shared papers, 2016–2024 · strength 0.40
  9. Rolf A. Brekken · 3 shared papers, 2017–2024 · strength 0.37
  10. Anirban Maitra · 4 shared papers, 2018–2022 · strength 0.32
  11. Matthew H. G. Katz · 4 shared papers, 2016–2022 · strength 0.29
  12. Huamin Wang · 4 shared papers, 2016–2022 · strength 0.29
  13. Paul J. Chiao · 3 shared papers, 2016–2022 · strength 0.24
  14. Michela Capello · 2 shared papers, 2020–2022 · strength 0.19
  15. Ehsan Irajizad · 2 shared papers, 2020–2022 · strength 0.19
  16. Jody V. Vykoukal · 2 shared papers, 2020–2022 · strength 0.19
  17. Laura R. Prakash · 2 shared papers, 2020–2022 · strength 0.19
  18. Johannes Francois Fahrmann · 2 shared papers, 2020–2022 · strength 0.19
  19. Samir Hanash · 2 shared papers, 2020–2022 · strength 0.19
  20. Robert A. Wolff · 2 shared papers, 2015–2018 · strength 0.12
  21. Yihui Chen · 1 shared paper, 2022 · strength 0.12
  22. Deyali Chatterjee · 2 shared papers, 2016–2018 · strength 0.10
  23. David R Piwnica-Worms · 1 shared paper, 2019 · strength 0.08
  24. Subrata Sen · 1 shared paper, 2019 · strength 0.08
  25. Prasanta Dutta · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.